FDA Approvals
FDA Approvals
- New Continuous Glucose Monitor Software Improves Accuracy
- Alert Pertuzumab Approved for HER2 Breast Cancer
- First Cord-Blood Transplant Therapy Approved by FDA
- FDA Approves Cetuximab for Metastatic Head and Neck Cancer
- Aneurysm Stent Okayed for Patients With Small Arteries
- FDA Okays Exparel for Postoperative Pain
- FDA Approves First Generic Versions of Olanzapine
- FDA Okays Exenatide as Adjunct to Insulin Glargine
- FDA Okays 2 Lower-Strength Testosterone Patches
- FDA Approves Deferiprone for Iron Overload
- FDA Approves Inhalation Spray for COPD
- Tadalafil Approved for Benign Prostatic Hyperplasia
- Gel to Control Bleeding During Surgery Gets FDA Nod
- Diaphragm Pacing System Gets FDA Nod for ALS
- FDA Okays Infliximab for Pediatric Ulcerative Colitis
- Eculizumab Approved for Rare Pediatric Blood Disorder
- FDA Approves Denosumab for Patients With Cancer
- FDA Clears Brachytherapy System for Brain Cancer
- FDA Approves Multicolor Pattern Scan Laser for Eye Surgery
- FDA Approves New Drug for Advanced NSCLC